{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:53:29Z","timestamp":1788872009542,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.thromres.2012.12.002","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T19:31:15Z","timestamp":1356204675000},"page":"225-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation"],"prefix":"10.1016","volume":"131","author":[{"given":"Naoki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Habe-Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Isaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2012.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4065\/76.11.1154","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"76","author":"Elliott","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.thromres.2012.12.002_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2012.12.002_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2257.2005.00704.x","article-title":"Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation","volume":"27","author":"Banno","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.thromres.2012.12.002_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1432-2277.1999.tb00627.x","article-title":"Hemolytic uremic syndrome in small-bowel transplant recipients: the first two case reports","volume":"12","author":"Humar","year":"1999","journal-title":"Transpl Int"},{"key":"10.1016\/j.thromres.2012.12.002_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","article-title":"FK506-associated thrombotic microangiopathy: report of two cases and review of the literature","volume":"67","author":"Trimarchi","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2012.12.002_bb0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/lt.21253","article-title":"Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation","volume":"13","author":"Miyata","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.thromres.2012.12.002_bb0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(84)90842-0","article-title":"Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient","volume":"2","author":"Bonser","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2012.12.002_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007890-199301000-00039","article-title":"FK506-associated thrombotic thrombocytopenic purpura","volume":"55","author":"Holman","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2012.12.002_bb0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1034\/j.1399-0012.2000.140314.x","article-title":"Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation","volume":"14","author":"Rerolle","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.thromres.2012.12.002_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1034\/j.1399-3062.2003.00019.x","article-title":"Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review","volume":"5","author":"Ramasubbu","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.thromres.2012.12.002_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.TP.0000165048.00487.8E","article-title":"Thrombotic microangiopathy in living-donor liver transplantation","volume":"80","author":"Tamura","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2012.12.002_bb0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/lt.20733","article-title":"Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases","volume":"12","author":"Ko","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.thromres.2012.12.002_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.thromres.2009.03.010","article-title":"Decreased ADAMTS13 Levels in Patients after Living Donor Liver Transplantation","volume":"124","author":"Kobayashi","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.12.002_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor- cleaving protease?","volume":"130","author":"Soejima","year":"2001","journal-title":"J Biochem"},{"key":"10.1016\/j.thromres.2012.12.002_bb0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpula","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2012.12.002_bb0080","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2012.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.12.002_bb0090","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor-cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.12.002_bb0095","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","article-title":"Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity","volume":"99","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2012.12.002_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.seminhematol.2003.10.009","article-title":"The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"41","author":"Matsumoto","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2012.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2012.12.002_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P","article-title":"Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura","volume":"57","author":"Chow","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2012.12.002_bb0115","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1615883","article-title":"Structure and function of von Willebrand factor","volume":"82","author":"Ruggeri","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.12.002_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.thromres.2012.12.002_bb0125","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D- vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.12.002_bb0130","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2006-09-043117","article-title":"VWF propeptide: a useful marker in VWD","volume":"108","author":"Federici","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.12.002_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12185-010-0732-4","article-title":"Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome","volume":"93","author":"Ito-Habe","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.thromres.2012.12.002_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2012.12.002_bb0145","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703544","article-title":"Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2012.12.002_bb0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.TP.0000062782.60563.CA","article-title":"Successful adult ABO-incompatible liver transplantation: therapeutic strategy for thrombotic microangiopathy is the key to success","volume":"75","author":"Sekido","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2012.12.002_bb0155","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.lts.2003.09.021","article-title":"Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report","volume":"9","author":"Nakazawa","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.thromres.2012.12.002_bb0160","article-title":"Severe post-thrombotic syndrome is associated with higher levels of factor VIII","author":"Bittar","year":"2012","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812008572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812008572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:36:20Z","timestamp":1758735380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812008572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0049384812008572"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.12.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2012.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}